Aptabio Therapeutics Inc. (293780)
Market Closed
15 Oct, 06:30 AM
KRX SM KRX SM Primary ₩
6,590. 00
-60
-0.9023%
₩
227.15B Market Cap
- P/E Ratio
- Div Yield
118,655 Volume
- Eps
₩ 6,650
Previous Close Want to track 293780 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aptabio Therapeutics Inc. (293780) Statistics
Valuation metrics
Market Cap 227.15B
Enterprise value 213.26B
Trailing P/E (ttm) -14.33
Forward P/E -
PEG ratio -0.3
Price/Sales (ttm) 46.93
Price/Book (mrq) 5.29
Enterprise Value/Revenue 44.87
Enterprise Value/EBITDA -9.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 86.04K
Average volume (90 days) 60.66K
Price summary
52-Week low 3,870
52-Week high 10,890
Beta -
50-Day moving average 6,624.38
200-Day moving average 6,108.88
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 2:1
Last split Date 24 Aug 2021
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.13%
Operating margin -3.87%
Operational effectiveness
Return on assets -0.27%
Return on equity -0.34%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 169.18
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -529.27
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 552.15
Total debt (mrq) -
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 2.54%
Book value per share (mrq) 1,502.15
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
